Literature DB >> 24242757

Molecular analysis of diffuse intrinsic brainstem gliomas in adults.

German Reyes-Botero1, Marine Giry, Karima Mokhtari, Marianne Labussière, Ahmed Idbaih, Jean-Yves Delattre, Florence Laigle-Donadey, Marc Sanson.   

Abstract

Diffuse intrinsic brainstem gliomas (DIBG) account for 1-2 % of adult gliomas. Their biological characteristics are scarcely understood and whether DIBG are biologically different from supratentorial gliomas remains to be established. We analyzed 17 DIBG samples for IDH1 R132H, alpha internexin, p53, and Ki67 expression, and, in a subset with sufficient DNA amount, for IDH1 and histone H3 mutational status, genomic profiling and MGMT promoter methylation status. A series of 738 adult supratentorial gliomas was used for comparison. Median age at diagnosis was 41 years (range 18.9-65.3 years). Median overall survival was 48.7 months (57 months for low-grade vs. 16 months for high-grade gliomas, p < 0.01). IDH1 sequencing revealed two mutations (IDH1 (R132G) , IDH1 (R132C) ) out of 7 DIBG whereas the R132H IDH1 enzyme was detected in 1/17 DIBG, suggesting that IDH1 mutations are mostly non R132H in DIBG (2/2), in contrast to supratentorial gliomas (31/313; p = 0.01). Mutations in histone genes H3F3A (encoding H3.3) and HIST1H3B (encoding H3.1) were found in 3/8 (37.5 %) of the DIBG (two H3F3A (K27M) and one HIST1H3B (K27M) ) versus 6/205 (2.9 %) of the supratentorial high-grade gliomas (four H3F3A (G34R) and two H3F3A (K27M) ) (p = 0.002). The CGH array showed a higher frequency of chromosome arm 1q gain, 9q gain and 11q loss in DIBG compared to the supratentorial high-grade gliomas, which had a less frequent chromosome 7 gain, and a less frequent chromosome 10 loss. No EGFR amplification was found. These data suggest that adult DIBG differ from adult supratentorial gliomas. In particular, histone genes (H3F3A (K27M) , HIST1H3B (K27M) ) mutations are frequent in adult DIBG whereas IDH1 (R132H) mutations are rare.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24242757     DOI: 10.1007/s11060-013-1312-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  30 in total

1.  Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.

Authors:  Jeremy Schwartzentruber; Andrey Korshunov; Xiao-Yang Liu; David T W Jones; Elke Pfaff; Karine Jacob; Dominik Sturm; Adam M Fontebasso; Dong-Anh Khuong Quang; Martje Tönjes; Volker Hovestadt; Steffen Albrecht; Marcel Kool; Andre Nantel; Carolin Konermann; Anders Lindroth; Natalie Jäger; Tobias Rausch; Marina Ryzhova; Jan O Korbel; Thomas Hielscher; Peter Hauser; Miklos Garami; Almos Klekner; Laszlo Bognar; Martin Ebinger; Martin U Schuhmann; Wolfram Scheurlen; Arnulf Pekrun; Michael C Frühwald; Wolfgang Roggendorf; Christoph Kramm; Matthias Dürken; Jeffrey Atkinson; Pierre Lepage; Alexandre Montpetit; Magdalena Zakrzewska; Krzystof Zakrzewski; Pawel P Liberski; Zhifeng Dong; Peter Siegel; Andreas E Kulozik; Marc Zapatka; Abhijit Guha; David Malkin; Jörg Felsberg; Guido Reifenberger; Andreas von Deimling; Koichi Ichimura; V Peter Collins; Hendrik Witt; Till Milde; Olaf Witt; Cindy Zhang; Pedro Castelo-Branco; Peter Lichter; Damien Faury; Uri Tabori; Christoph Plass; Jacek Majewski; Stefan M Pfister; Nada Jabado
Journal:  Nature       Date:  2012-01-29       Impact factor: 49.962

Review 2.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

Authors:  Therese A Dolecek; Jennifer M Propp; Nancy E Stroup; Carol Kruchko
Journal:  Neuro Oncol       Date:  2012-11       Impact factor: 12.300

3.  Glioblastomas with an oligodendroglial component: a pathological and molecular study.

Authors:  J He; K Mokhtari; M Sanson; Y Marie; M Kujas; S Huguet; P Leuraud; L Capelle; J Y Delattre; J Poirier; K Hoang-Xuan
Journal:  J Neuropathol Exp Neurol       Date:  2001-09       Impact factor: 3.685

4.  Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma.

Authors:  Jacques Grill; Stephanie Puget; Felipe Andreiuolo; Cathy Philippe; Laura MacConaill; Mark W Kieran
Journal:  Pediatr Blood Cancer       Date:  2011-12-20       Impact factor: 3.167

5.  Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas.

Authors:  Jennifer Barrow; Martyna Adamowicz-Brice; Maria Cartmill; Donald MacArthur; James Lowe; Keith Robson; Marie-Anne Brundler; David A Walker; Beth Coyle; Richard Grundy
Journal:  Neuro Oncol       Date:  2010-12-07       Impact factor: 12.300

6.  Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951.

Authors:  Karima Mokhtari; François Ducray; Johan M Kros; Thierry Gorlia; Ahmed Idbaih; Martin Taphoorn; Pieter Wesseling; Khe Hoang-Xuan; Martin Van den Bent; Marc Sanson
Journal:  Cancer       Date:  2011-01-18       Impact factor: 6.860

7.  Brainstem gliomas in adults: prognostic factors and classification.

Authors:  J S Guillamo; A Monjour; L Taillandier; B Devaux; P Varlet; C Haie-Meder; G L Defer; P Maison; J J Mazeron; P Cornu; J Y Delattre
Journal:  Brain       Date:  2001-12       Impact factor: 13.501

8.  Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases.

Authors:  Arie Perry; C Ryan Miller; Meena Gujrati; Bernd W Scheithauer; Sandro Casavilca Zambrano; Sarah C Jost; Ravi Raghavan; Jiang Qian; Elizabeth J Cochran; Jason T Huse; Eric C Holland; Peter C Burger; Marc K Rosenblum
Journal:  Brain Pathol       Date:  2008-04-29       Impact factor: 6.508

9.  Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

Authors:  Dominik Sturm; Hendrik Witt; Volker Hovestadt; Dong-Anh Khuong-Quang; David T W Jones; Carolin Konermann; Elke Pfaff; Martje Tönjes; Martin Sill; Sebastian Bender; Marcel Kool; Marc Zapatka; Natalia Becker; Manuela Zucknick; Thomas Hielscher; Xiao-Yang Liu; Adam M Fontebasso; Marina Ryzhova; Steffen Albrecht; Karine Jacob; Marietta Wolter; Martin Ebinger; Martin U Schuhmann; Timothy van Meter; Michael C Frühwald; Holger Hauch; Arnulf Pekrun; Bernhard Radlwimmer; Tim Niehues; Gregor von Komorowski; Matthias Dürken; Andreas E Kulozik; Jenny Madden; Andrew Donson; Nicholas K Foreman; Rachid Drissi; Maryam Fouladi; Wolfram Scheurlen; Andreas von Deimling; Camelia Monoranu; Wolfgang Roggendorf; Christel Herold-Mende; Andreas Unterberg; Christof M Kramm; Jörg Felsberg; Christian Hartmann; Benedikt Wiestler; Wolfgang Wick; Till Milde; Olaf Witt; Anders M Lindroth; Jeremy Schwartzentruber; Damien Faury; Adam Fleming; Magdalena Zakrzewska; Pawel P Liberski; Krzysztof Zakrzewski; Peter Hauser; Miklos Garami; Almos Klekner; Laszlo Bognar; Sorana Morrissy; Florence Cavalli; Michael D Taylor; Peter van Sluis; Jan Koster; Rogier Versteeg; Richard Volckmann; Tom Mikkelsen; Kenneth Aldape; Guido Reifenberger; V Peter Collins; Jacek Majewski; Andrey Korshunov; Peter Lichter; Christoph Plass; Nada Jabado; Stefan M Pfister
Journal:  Cancer Cell       Date:  2012-10-16       Impact factor: 31.743

10.  Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

Authors:  Marc Sanson; Yannick Marie; Sophie Paris; Ahmed Idbaih; Julien Laffaire; François Ducray; Soufiane El Hallani; Blandine Boisselier; Karima Mokhtari; Khe Hoang-Xuan; Jean-Yves Delattre
Journal:  J Clin Oncol       Date:  2009-07-27       Impact factor: 44.544

View more
  25 in total

1.  Adult brainstem gliomas: Correlation of clinical and molecular features.

Authors:  Brett J Theeler; Benjamin Ellezam; Isaac Melguizo-Gavilanes; John F de Groot; Anita Mahajan; Kenneth D Aldape; Janet M Bruner; Vinay K Puduvalli
Journal:  J Neurol Sci       Date:  2015-04-18       Impact factor: 3.181

Review 2.  Evidence-Based Practice: Temozolomide Beyond Glioblastoma.

Authors:  Jason Chua; Elizabeth Nafziger; Denise Leung
Journal:  Curr Oncol Rep       Date:  2019-03-05       Impact factor: 5.075

3.  Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations.

Authors:  David A Solomon; Matthew D Wood; Tarik Tihan; Andrew W Bollen; Nalin Gupta; Joanna J J Phillips; Arie Perry
Journal:  Brain Pathol       Date:  2015-12-14       Impact factor: 6.508

4.  Adult diffuse midline gliomas: Clinical, radiological, and genetic characteristics.

Authors:  Antonio Dono; Takeshi Takayasu; Leomar Y Ballester; Yoshua Esquenazi
Journal:  J Clin Neurosci       Date:  2020-11-01       Impact factor: 1.961

5.  Temozolomide after radiotherapy in recurrent "low grade" diffuse brainstem glioma in adults.

Authors:  Germán Reyes-Botero; Florence Laigle-Donadey; Karima Mokhtari; Nadine Martin-Duverneuil; Jean-Yves Delattre
Journal:  J Neurooncol       Date:  2014-08-20       Impact factor: 4.130

6.  High Jagged1 expression is associated with poor outcome in primary glioblastoma.

Authors:  Xian-Xin Qiu; Chen-Hong Wang; Na You; Bi-Juan Chen; Xing-Fu Wang; Yu-Peng Chen; Zhi-Xiong Lin
Journal:  Med Oncol       Date:  2014-11-26       Impact factor: 3.064

7.  Diagnostic challenges, management and outcomes of midline low-grade gliomas.

Authors:  Mueez Waqar; Shahid Hanif; Nitika Rathi; Kumar Das; Rasheed Zakaria; Andrew R Brodbelt; Carol Walker; Michael D Jenkinson
Journal:  J Neurooncol       Date:  2014-08-06       Impact factor: 4.130

8.  TP53 and p53 statuses and their clinical impact in diffuse low grade gliomas.

Authors:  Emeline Gillet; Agusti Alentorn; Brahima Doukouré; Emeline Mundwiller; Hinke F van Thuijl; Hinke van Thuij; Jaap C Reijneveld; José Alfonso Meza Medina; Amélie Liou; Yannick Marie; Karima Mokhtari; Khê Hoang-Xuan; Marc Sanson; Jean-Yves Delattre; Ahmed Idbaih
Journal:  J Neurooncol       Date:  2014-03-04       Impact factor: 4.130

9.  IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification.

Authors:  Giulia Berzero; Anna Luisa Di Stefano; Susanna Ronchi; Franck Bielle; Chiara Villa; Erell Guillerm; Laurent Capelle; Bertrand Mathon; Alice Laurenge; Marine Giry; Yohann Schmitt; Yannick Marie; Ahmed Idbaih; Khe Hoang-Xuan; Jean-Yves Delattre; Karima Mokhtari; Marc Sanson
Journal:  Neuro Oncol       Date:  2021-06-01       Impact factor: 12.300

10.  Characteristics of cerebellar glioblastomas in adults.

Authors:  Thiébaud Picart; Marc Barritault; Julien Berthillier; David Meyronet; Alexandre Vasiljevic; Didier Frappaz; Jérôme Honnorat; Emmanuel Jouanneau; Delphine Poncet; François Ducray; Jacques Guyotat
Journal:  J Neurooncol       Date:  2017-12-01       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.